Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.